Skip to main content
  • Treatment of Blister-Like Aneurysms with the Pipeline Embolization Device.

    Final Number:
    1059

    Authors:
    Nohra Chalouhi MD; Mario Zanaty MD; Stavropoula I. Tjoumakaris MD; Fernando Gonzalez; David M. Hasan MD; David K. Kung MD; Robert H. Rosenwasser MD, FACS, FAHA; Pascal Jabbour MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: Flow-diversion with pipeline embolization device (PED) is recently gaining ground. Data on the safety and efficacy of the PED in blister-like aneurysms (BLAs) are limited. We aim to present our with the use of the PED in BLAs

    Methods: A total of 8 patients harboring 8 BLAs were treated with the PED at our institution between November 2011 and April 2013

    Results: The average aneurysm size was 2.5 mm. Five patients had sustained a subarachnoid hemorrhage (SAH), 1 patient presented with sentinel headaches, and in 2 patients the aneurysm was incidentally discovered. Seven aneurysms arose from the ICA and 1 from the basilar artery. Placement of the PED was successful in all 8 patients. There were no procedural or perioperative complications in any of the patients. At the latest follow-up, all 8 patients achieved a favorable outcome (mRS 0-2). Angiographic follow-up was available for 6 patients at a mean time point of 3.9 months. Follow-up angiography showed 100% aneurysm occlusion in 5 patients and marked decrease in aneurysm size in 1 patient.

    Conclusions: The findings of this study suggest that the PED may be a safe and effective treatment for BLAs. Given the limitations of other treatment modalities and the challenging nature of BLAs, flow diversion may be a valuable option for these lesions..

    Patient Care: This presents a suitable alternative for endovascular treatment of Blister like aneurysm with favorable outcome. This study justify a future work that compares PED with other endovascular modalities.

    Learning Objectives: PED is a safe and effective treatment for BLAs with favorable outcomes. in this study, PED use had no morbimortality and achieved a satisfactory complete occlusion rate of 62.5%

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy